Xylem (NYSE:XYL) Earns Buy Rating from Analysts at UBS Group

UBS Group assumed coverage on shares of Xylem (NYSE:XYL) in a research note released on Tuesday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $165.00 price target on the industrial products company’s stock.

A number of other equities analysts have also recently commented on XYL. Argus lifted their price objective on shares of Xylem from $146.00 to $165.00 and gave the stock a buy rating in a research report on Wednesday, May 29th. Mizuho lifted their target price on shares of Xylem from $110.00 to $135.00 and gave the stock a neutral rating in a report on Friday, May 3rd. TD Cowen raised their price objective on shares of Xylem from $135.00 to $138.00 and gave the stock a buy rating in a research report on Thursday, June 6th. Robert W. Baird boosted their price objective on Xylem from $155.00 to $170.00 and gave the stock an outperform rating in a report on Wednesday, July 31st. Finally, Stifel Nicolaus lifted their price target on Xylem from $170.00 to $172.00 and gave the stock a buy rating in a report on Wednesday, July 31st. Five research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, Xylem currently has an average rating of Moderate Buy and an average target price of $147.54.

Xylem Stock Up 1.3 %

Shares of NYSE:XYL opened at $133.19 on Tuesday. The company has a 50 day moving average price of $135.61 and a two-hundred day moving average price of $132.12. The company has a market capitalization of $32.35 billion, a PE ratio of 47.40, a PEG ratio of 2.32 and a beta of 1.04. Xylem has a 52 week low of $87.59 and a 52 week high of $146.08. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.85.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, July 30th. The industrial products company reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.04. The company had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.14 billion. Xylem had a return on equity of 9.48% and a net margin of 9.11%. The company’s revenue for the quarter was up 26.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.98 earnings per share. Analysts forecast that Xylem will post 4.25 earnings per share for the current year.

Insider Activity

In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the sale, the chief accounting officer now directly owns 3,536 shares of the company’s stock, valued at approximately $490,195.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Xylem news, CAO Geri-Michelle Mcshane sold 2,278 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $138.63, for a total transaction of $315,799.14. Following the completion of the transaction, the chief accounting officer now owns 3,536 shares in the company, valued at approximately $490,195.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Rodney Aulick sold 21,800 shares of the business’s stock in a transaction dated Wednesday, June 5th. The shares were sold at an average price of $139.01, for a total value of $3,030,418.00. Following the completion of the transaction, the senior vice president now directly owns 76,287 shares in the company, valued at $10,604,655.87. The disclosure for this sale can be found here. Insiders own 0.27% of the company’s stock.

Institutional Trading of Xylem

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC raised its position in shares of Xylem by 68.8% during the first quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock worth $25,000 after purchasing an additional 77 shares during the period. Mark Sheptoff Financial Planning LLC acquired a new position in shares of Xylem during the second quarter valued at about $33,000. Blue Trust Inc. increased its position in shares of Xylem by 1,185.7% during the second quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock worth $35,000 after acquiring an additional 249 shares in the last quarter. FinTrust Capital Advisors LLC raised its holdings in shares of Xylem by 170.9% in the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock worth $41,000 after acquiring an additional 200 shares during the last quarter. Finally, Hazlett Burt & Watson Inc. boosted its stake in Xylem by 184.9% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock valued at $43,000 after purchasing an additional 220 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.